John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs
John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C. John C. Martin in 2006 with a bottle of Truvada, a groundbreaking treatment for H.I.V. made by his company, Gilead Sciences, in the Bay Area. Credit...Paul Sakuma/Associated Press April 27, 2021, 6:43 p.m. ET John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cure...